Delivery Order SPE2DB20D3104-SPE2DB24FV3Z5
- Not listed
- This federal contract award, with ID SPE2DB22D2007|SPE2DB25FH8CY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,290.00 firm fixed-price delivery order is for the procurement of Moderna COVID-19 vaccine doses for individuals aged 6 months to 11 years, under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of January 30, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under an Emergency Use Authorization. The $28,608.20 fixed-price delivery order contract has a completion date of July 9, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $16,888.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.25mL doses of the Moderna COVID-19 vaccine for individuals aged 6 months to 11 years, under the Emergency Use Authorization (EUA). The award has an ultimate completion date of October 20, 2023. This contract is a delivery order with a firm fixed-price...
- This federal contract award, valued at $6,361.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Moderna COVID-19 vaccines for ages 6 months to 11 years under the Emergency Use Authorization (EUA), with an ultimate completion date of September 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM7D0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,580.00, is a Firm Fixed Price Delivery Order to supply Moderna COVID-19 vaccine doses (0.25mL) for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of March 10, 2025....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Moderna COVID-19 vaccines for ages 6 months to 11 years old under an Emergency Use Authorization (EUA). The contract is a $4,752.75 firm fixed-price delivery order with an ultimate completion date of April 8, 2025. The contract is not a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of Moderna COVID-19 vaccines for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The contract, valued at $1,290.00, is a firm fixed-price delivery order contract with a completion date of March 12, 2025. The contract does not have a set-aside designation. Amerisourcebergen...
- This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,272.22 Firm Fixed Price contract is for the delivery of Moderna COVID-19 vaccine doses (0.25mL) for ages 6 months to 11 years under the Emergency Use Authorization. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen is a for-profit...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a $2,215.32 firm-fixed-price delivery order to supply Moderna COVID-19 vaccines for children aged 6 months to 11 years under the Emergency Use Authorization. This contract has no set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
- This federal contract award, valued at $4,556.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). This is a firm-fixed-price contract with a completion date of November 13, 2023. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB24FV3Z5Delivery Order
This federal contract award, with ID SPE2DB20D3104|SPE2DB24FV3Z5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $45,567.60 fixed-price delivery order is for the procurement of 0.25 mL doses of the Moderna COVID-19 vaccine for ages 6 months to 11 years, under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of December 20, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical commodities. These contract vehicles enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.6k | 11/29/23 |